血液检验项目正常参考值范围

血液检验项目正常参考值范围英語:),指的是医疗保健专家从血液样品中选取的一组用来描述医疗检验结果的正常参考值。

血液检验的测量值在临床中意义非常重要,人们通过对体液进行分析来寻找属于病理学中的病理改变来作为是否患病的参考,属于对临床化学(临床生化学、化学病理学、纯血液化学的总称)领域中的研究。

分类

离子及微量金属

这里包括了一些如含铁结合蛋白、含铜结合蛋白之类的一些蛋白质。

项目下限值上限值单位备注
(Na)135[1],137[2][3]145[2][3],147[1]mmol/L or mEq/L[1]
31[4], 32[4]33[4], 34[4]mg/dl
(K)3.5[1][3], 3.6[2]5.0[1][2][3], 5.1mmol/L or mEq/L[1]参见低钾血症
高钾血症
14[5]20[5]mg/dl
(Cl)95[1], 98[6], 100[3]105[1], 106[6], 110[3]mmol/L or mEq/L[1]
340[7]370[7]mg/dl
离子 (Ca)1.03[8], 1.10[3]1.23[8], 1.30[3]mmol/L
4.1 [9], 4.4[9]4.9 [9], 5.2[9]mg/dL
血清铁 (TSI) – 男性65[10], 76[2]176[10], 198[2]µg/dL
11.6[11][12], 13.6[12]30[11], 32[12], 35[12]μmol/L
总血清铁(TSI) – 女性26[2], 50[10]170[2][10]µg/dL
4.6[12], 8.9[11]30.4[11]μmol/L
总血清铁(TSI) - 新生儿100[10]250[10]µg/dL
18[12]45[12]µmol/L
总血清铁(TSI) - 儿童50[10]120[10]µg/dL
9[12]21[12]µmol/L
总铁结合力(TIBC)240[10], 262[2]450[10], 474[2]μg/dL
43[12], 47[12]81[12], 85[12]µmol/L
转铁蛋白190[13], 194[3], 204[2]326[3], 330[13], 360[2]mg/dL
25[14]45[14]μmol/L
饱和转铁蛋白20[10]50[10]%
– 男性12[15]300[15]ng/mL
27 [16]670[16]pmol/L
铁 – 女性12[15]150[15]ng/mL
27 [16]330[16]pmol/L
10[17], 20[18]35[17], 65[18]μmol/L
17[19], 34[19]60[19], 110[19]μg/dL
70[20]150[20]µg/dL
11 [21]24[21]μmol/L
铜蓝蛋白15[20]60[20]mg/dL
1 [22]4[22]μmol/L
钙总量 (Ca)2.1[1][23], 2.2[3]2.5[23][3], 2.6[23], 2.8[1]mmol/L
8.4[1], 8.5[20]10.2[1], 10.5[20]mg/dL
磷酸 (HPO42−)0.81.5 [24]mmol/L
无机 (血清)1.0[1]1.5[1]mmol/L
3.0[1]4.5[1]mg/dL
(Cu)11[25]24μmol/L
(Zn)60 [26], 72[27]110[27], 130[26]μg/dL
9.2[28], 11[3]17[3], 20[28]µmol/L
1.5[20], 1.7[29]2.0[20], 2.3[29]mEq/L or mg/dL
0.6[30], 0.7[3]0.82[30], 0.95[3]mmol/L
(最适范围)120[31]μg/L

酸碱缓冲对

酸碱缓冲对如果没有特别指定为动脉/静脉血,一般指的是动脉血,而不是静脉血。

酸碱缓冲对中的少数项目在动脉/静脉中差异很大。[32]

项目动脉/静脉下限值上限值单位备注
pH动脉7.34[2], 7.35[1]7.44[2], 7.45[1]
静脉7.31[33]7.41[33]
[H+]动脉36[1]44[1]nmol/L
3.6 [34]4.4[34]ng/dL
过剰碱基动脉和静脉[33]-3[33]+3[33]mEq/L
分圧 (pO2)动脉10[1], 11[35]13[35], 14[1]kPa
75[1][2], 83[20]100[2], 105[1]mmHg 又はtorr
静脉4.0[35]5.3[35]kPa
30[33]40[33]mmHg 又は torr
氧饱和度动脉94[33], 95[6], 96[20]100[6][20]%
静脉Approximately 75[6]
二氧化碳分压 (CO2)动脉4.4[1], 4.7[35]5.9[1], 6.0[35]kPa指定pCO2
33[1], 35[2]44[1], 45[2]mmHg 或 torr
23[33]30[33]mmol/L
100[36]132[36]mg/dL
静脉5.5[35]6.8[35]kPa
41[33]51[33]mmHg 又は torr
碳酸氢根离子 (HCO3, )动脉和静脉18[20]23[20]mmol/L
110[37]140[37]mg/dL
标准碳酸氢根离子(SBCe)动脉和静脉21, 22[1]27, 28[1]mmol/L or mEq/L[1]
134[37]170[37]mg/dL

肝功能

项目检验者类型下限值上限值单位备注
总蛋白60[1], 63[2]78[1], 82[2], 84[20]g/L参见低蛋白血症
白蛋白35[1][38]48[2], 55[1]g/L参见低蛋白血症
3.5[2]4.8[2], 5.5[1]U/L
540[39]740[39]μmol/L
球蛋白23[1]35[1]g/L
总胆红素1.7[40], 2[1], 3.4[40], 5[3]17[1][40], 22[40], 25[3]μmol/L
0.1[1], 0.2[2], 0.29[41]1.0[1][20], 1.3[2], 1.4[41]mg/dL
结合型/直接胆红素0.0[1] or N/A[3]5[1], 7[40][3]μmol/L
0[1][2]0.3[1][2], 0.4[20]mg/dL
丙氨酸转氨酶(ALT/ALAT[3])5[42], 7[2], 8[1]20[1], 21[6], 56[2]U/L也被称为血清谷丙转氨酶
(SGPT:serum glutamic pyruvic transaminase)
女性0.15[3]0.75[3]µkat/L
男性0.15[3]1.1[3]
天冬氨酸氨基转移酶(AST/ASAT[3])女性6[43]34[43]IU/L也被称为

血清谷草转氨酶
(SGOT:serum glutamic oxaloacetic transaminase)

0.25[3]0.60[3]µkat/L
男性8[43]40[43]IU/L
0.25[3]0.75[3]µkat/L
碱性磷酸酶(ALP)女性42[42]98[42]U/L
男性53[42]128[42]
酶活性0.6[3]1.8[3]µkat/L
γ-谷氨酰转移酶(GGT)5[42], 8[2]40[42], 78[2]U/L
女性0.8[44]µkat/L
男性1.3[44]

心肌酶

项目检验者类型下限值上限值单位备注
肌酸激酶 (CK)男性24[45], 38[2], 60[42]174[20], 320[42]U/L
or ng/mL
女性24[45], 38[2], 96[20]140[20], 200[42]
CK-MB03[2], 3.8[3], 5[42]ng/mL or μg/L[3]
脑利钠肽 (BNP)男性45-54 岁4[46]40[46]pg/mL
55-64 岁5[46]52[46]
65-74 岁7[46]67[46]
75-83 岁9[46]86[46]
女性45-54 岁8[46]73[46]
55-64 岁10[46]93[46]
65-74 岁13[46]120[46]
75-83 岁16[46]155[46]
NT-proBNP男性< 45 岁90[47]pg/mL
45-54 岁140[47]
55-64 岁180[47]
65-74 岁230[47]
> 75 岁850[47]
女性< 45 岁180[47]
45-54 岁190[47]
55-64 岁230[47]
65-74 岁350[47]
> 75 岁620[47]
肌红蛋白女性1[48]66[48]ng/mL or µg/L
男性17[48]106[48]

疼痛开始12小时后肌钙蛋白的值:

项目下限值上限值单位参考
肌钙蛋白I0.2[49]ng/mL or μg/L通常的上限
0.2[49]1.0[49]ng/mL or μg/L急性冠脉综合征
0.4[50]2.0[50]ng/mL or μg/L平稳上升[50]
1.0[49], 1.5[51]n/a[49][51]ng/mL or μg/L疑似心肌梗塞
肌钙蛋白T0.02[49]ng/mL or μg/L通常的上限
0.02[49]0.10[49]ng/mL or μg/L急性冠脉综合征
0.10[49]n/a[49]ng/mL or μg/L疑似心肌梗塞

肿瘤标志物

项目下限值上限值单位备注
甲胎蛋白 (AFP)044[2]ng/mL
β人绒毛膜促性腺激素 (bHCG)n/a5[2]IU/l or mU/ml男性及非孕妇
CA 19-9n/a40[2]U/ml
CA-125n/a30[52], 35[53]kU/L or U/mL
癌胚抗原 (CEA)
50岁的非吸烟者
n/a3.4[3], 3.6 [54]μg/l
癌胚抗原 (CEA)
70岁的非吸烟者
n/a4.1[54]μg/l
癌胚抗原 (CEA) - 吸烟者n/a5[55]μg/l
前列腺特异抗原 (PSA)n/a2.5[3], 4[2]μg/L[2][3] or ng/mL[20]45岁以下 <2,5 μg/L
前列腺酸性磷酸酶(PAP)03[20]units/dL (Bodansky units)

甲状腺激素

项目检验者类型下限值上限值单位
促甲状腺激素
(TSH or thyrotropin)
成人 -
通常范围
0.3[3], 0.4[2], 0.5[20], 0.6[56]4.0[3], 4.5[2], 6.0[20]mIU/L or μIU/mL
成人 -
最适范围
0.3[57], 0.5[58]2.0[58], 3.0[57]mIU/L or μIU/mL
婴儿1.3[59]19[59]mIU/L or μIU/mL
游离甲状腺素 (FT4)通常的成人0.7[60],0.8[2]1.4[60], 1.5[2]ng/dL
9[61][3], 10[62], 12 [63]18[3][61], 23[63]pmol/L
婴儿 0-3日2.0[60]5.0[60]ng/dL
26[61]65[61]pmol/L
婴儿 3-30日0.9[60]2.2[60]ng/dL
12[61]30[61]pmol/L
儿童/青春期
30日 - 18岁
0.8[60]2.0[60]ng/dL
10[61]26[61]pmol/L
孕妇0.5[60]1.0[60]ng/dL
6.5[61]13[61]pmol/L
总甲状腺素60[62][63]140[62], 160[63]nmol/L
4[62], 5.5[2]11[62], 12.3[2]μg/dL
游离三碘甲状腺原氨酸 (FT3)通常的成人0.2[62]0.5[62]ng/dL
3.1[64]7.7[64]pmol/L
儿童 2-16岁0.1[65]0.6[65]ng/dL
1.5[64]9.2[64]pmol/L
总三碘甲状腺原氨酸0.9[3], 1.1[62]2.5[3], 2.7[62]nmol/L
60[2], 75[62]175[62], 181[2]ng/dL
甲状腺素结合球蛋白 (TBG)12[2]30[2]mg/L
甲状腺球蛋白 (Tg)1.5[62]30[62]pmol/L
1[62]20 [62]μg/L

性激素

项目检验者类型下限值上限值单位
睾丸酮男性, 整体8 [66], 10[67]27 [66], 35[67]nmol/L
230 [68], 300 [69]780[68] - 1000[69]ng/dL
男性 < 50 岁10[3]45[3]nmol/L
290[68]1300[68]ng/dL
男性 > 50 岁6.2[3]26[3]nmol/L
180[68]740[68]ng/dL
女性0.7[67]2.8[67] - 3.0[3]nmol/L
20[69]80[69] - 85[68]ng/dL
17-羟基孕酮男性0.06[20]3.0[20]mg/L
女性 (卵泡期)0.2[20]1.0[20]mg/L
卵泡刺激素 (FSH)青春期前<1 [70]3[70]IU/L
成人男性1[70]8[70]
成人女性 (卵泡期及黄体期)1[70]11[70]
成人女性 (排卵)6[70]
95% PI (standard)
26[70]
95% PI)
5[71]
90% PI (used in diagram)
15[71]
(90% PI)
闭经后女性30[70]118[70]
黄体生成素 (LH)女性, peak20[71]
90% PI (used in diagram)
75[71]
(90% PI)
IU/L
女性, 闭经后15[72]60[72]
雌二醇 (雌激素的一种)成人男性50[73]200[73]pmol/L
1.4[74]5.5[74]ng/dL
成人女性 (卵泡期,5日)70[73]
95% PI (standard)
500[73]
95% PI
pmol/L
110[71]
90% PI (used in diagram)
220[71]
90% PI
1.9[74] (95% PI)14[74] (95% PI)ng/dL
3.0[74] (90% PI)6.0[74] (90% PI)
成人女性 (排卵前)400[73]1500[73]pmol/L
11[74]41[74]ng/dL
成人女性(黄体期)70[73]600[73]pmol/L
1.9[74]16[74]ng/dL
成人女性 - free (not protein bound)0.05[75]0.9[75]ng/dL
1.7[75]33[75]pmol/L
闭经后女性N/A [73]< 130[73]pmol/L
N/A[74]< 3.5[74]ng/dL
黄体激素女性(排卵日)2.2[71] (90% PI)9[71] (90% PI)nmol/L
70[76] (90% PI)280[76] (90% PI)ng/dL
雄烯二酮成人男性及女性60[72]270[72]ng/dL
闭经后女性< 180[72]
青春期前< 60[72]

其他激素

项目检验者类型下限值上限值单位
副肾皮质刺激激素 (ACTH)4.4[77]18[78],22[77]pmol/L
20[2]80[79], 100[2]pg/mL
皮质醇上午09:00140[80]700[80]nmol/L
5[81]25[81]μg/dL
深夜80[80]350[80]nmol/L
2.9[81]13[81]μg/dL
生长激素 (空腹时)05[1]ng/mL
生长激素 (精氨酸刺激)7[1]n/ang/mL
催乳素女性n/a20[2]ng/mL or µg/L[3]
男性15[2]
甲状旁腺激素 (PTH)10[82], 17[83]65[82], 70[83]pg/mL
1.1[3], 1.8[84]6.9[3], 7.5[84]pmol/L
25-羟胆钙化(固)醇 (维生素D的一种)
- 通常参考值
8[20][85], 9[85]40[85], 80[20]ng/mL
20[86], 23[87]95[87], 150[86]nmol/L
25-羟胆钙化(固)醇
- 治疗时参考值
30[88], 40[89]65[89], 100[88]ng/mL
85[31], 100[89]120[31], 160[89]nmol/L

氨基酸

项目性别年龄下限值上限值单位异常上升值最适值
同型半胱氨酸女性12–19 岁3.3 [90]7.2[90]μmol/L> 10.4 μmol/L
or
> 140 μg/dl
< 6.3 μmol/L [31]
or
< 85 μg/dL[31]
45[91]100[91]μg/dL
>60 岁4.9 [90]11.6 [90]μmol/L
66[91]160[91]μg/dL
男性12–19 岁4.3 [90]9.9 [90]μmol/L> 11.4 μmol/L
or
> 150 μg/dL
60[91]130[91]μg/dL
>60 岁5.9 [90]15.3 [90]μmol/L
80[91]210[91]μg/dL

维生素类

项目检验者类型标准范围单位最适范围
下限值上限值下限值上限值
维生素A30[20]65[20]µg/dL
维生素B9
(叶酸/叶酸盐) - 血清
1岁以上3.0[92]16[92]ng/mL or μg/L5 [93]
6.8[94]36[94]nmol/l11[94]
维生素B9
(叶酸/叶酸盐) - 红细胞
200[92]600[92]ng/mL or μg/L
450[94]1400[94]nmol/L
孕妇ng/mL or μg/L400[92]
nmol/L900[92]
维生素B12 (钴胺素)130[95], 160[96]700[95], 950[96]ng/L
100[97], 120[3]520[97], 700[3]pmol/L
维生素C (抗坏血酸)0.4[20]1.5[20]mg/dL0.9[31]
23[98]85[98]μmol/L50[31]
25-羟胆钙化(固)醇 (维生素D)8[20][85], 9[85]40[85], 80[20]ng/mL30[88], 40[89]65[89], 100[88]
20[86], 23[87]95[87], 150[86]nmol/L85[31], 100[89]120[31], 160[89]
维生素Eμmol/L28[31]
mg/dL1.2[31]

有害物质

项目参考种类参考值单位
健康的维持< 20[6] or 40[20]µg/dL
乙醇酒驾参考0[99], 0.2[99], 0.8[99] or g/L
17.4[100]mmol/L

红细胞

项目检验者类型下限值上限值单位备注
血红蛋白 (Hb)男性2.0[101], 2.1[1]2.5[101], 2.7[1]mmol/L婴儿高,儿童低。
130[3], 132[2], 135[1]162[2], 170[3], 175[1]g/L
女性1.8[101], 1.9[1]2.3[101], 2.5[1][101]mmol/L成人间性别差异很小。
120[3] [1][2]150[3], 152[2], 160[1][20]g/L
血浆中血红蛋白0.16[1]0.62[1]μmol/L通常仅存在于小型红细胞内。
14mg/dL
糖化血红蛋白 (HbA1c)< 50 岁3.6[3]5.0[3]% of Hb
> 50 岁3.9[3]5.3[3]
结合珠蛋白< 50 岁0.35[3]1.9[3]g/L
> 50 岁0.47[3]2.1[3]
红细胞比容 (Hct)男性0.39[3], 0.4[2], 0.41[1], 0.45[20]0.50[3], 0.52[2],0.53[1], 0.62[20]
女性0.35[3], 0.36[1],0.37[2][20]0.46[1][2][3], 0.48[20]
儿童0.31[2]0.43[2]
平均红细胞体积 (MCV)男性76[20], 82[2]100[20], 102[2]fL容积婴儿高,儿童低。
女性78[2]101[2]fL
红细胞粒度分布幅(Red blood cell distribution width (RDW))11.5[2]14.5[2]%
平均红细胞血红蛋白(Mean cell hemoglobin(MCH))0.39[1]0.54[1]fmol/cell
25[1], 27[20][3]32[20], 33[3], 35[1]pg/cell
平均红细胞血红蛋白浓度(Mean corpuscular hemoglobin concentration(MCHC))31[2], 32[20][3]35[2], 36[20][3]g/dL
4.8 [102], 5.0[102]5.4[102], 5.6[102]mmol/L
红细胞 (RBC)男性4.2[20], 4.3[1][2][3]5.7[3], 5.9[1], 6.2[2], 6.9[20]x1012/L
女性3.5[1], 3.8[2], 3.9[3]5.1[3], 5.5[1][2]x1012/L
婴儿/儿童3.8[2]5.5[2]x1012/L
网织红细胞26[3]130[3]x109/L
成人0.5[1][2]1.5[1][2]% of RBC
新生儿1.1[2]4.5[2]% of RBC
婴儿0.5[2]3.1[2]% of RBC

白细胞

项目检验者类型下限值上限值单位备注
白细胞数 (WBC)成人3.5[3], 3.9[103], 4.1[2], 4.5[1]9.0[3], 10.0[103], 10.9[2], 11[1]
  • x109/L
  • x103/mm3 or
  • x103/μL
新生儿9[104]30[104]
1岁婴儿6[104]18[104]
中性粒细胞 (A.K.A. grans, polys, PMNs, or segs)成人1.3[3], 1.8[103], 2[104]5.4[3], 7[103], 8[104]x109/L
45-54[1]62[1], 74% of WBC
新生儿6[104]26[104]x109/L
杆状单核细胞(中性粒细胞) (Neutrophilic band forms)成人0.7[104]x109/L
3[1]5[1]% of WBC
淋巴细胞成人0.7[3], 1.0[103][104]3.5[103], 3.9[3], 4.8[104]x109/L
16-25[1]33[1], 45% of WBC
新生儿2[104]11[104]x109/L
单核细胞成人0.1[3], 0.2[95][105]0.8[95][104][3]x109/L
3[1], 4.07[1], 10% of WBC
新生儿0.4[104]3.1[104]x109/L
单核白细胞(单核细胞+淋巴细胞)成人1.55x109/L
2035% of WBC
CD4阳性T细胞成人0.4 [2], 0.5[6]1.5[6], 1.8[2]x109/L
嗜酸性粒细胞成人0.0[3], 0.04[95]0.44[95], 0.45[104], 0.5[3]x109/L
1[1]3[1], 7% of WBC
新生儿0.02[104]0.85[104]x109/L
嗜碱性粒细胞成人40[103]100[95][3], 200[104], 900[103]x106/L
0.00.75[1], 2% of WBC
新生儿0.64 [104]x109/L

凝血・纤溶系统

项目下限值上限值单位备注
血小板/红细胞数 (Plt)140[2], 150[1][3]350[20][3], 400[1], 450[2]x109/L
凝血酶原时间 (PT)10[6], 11[1][106], 12[2]13[6], 13.5[106], 14[2], 15[1]s凝血酶原时间受到检测药剂不同的影响。INR可以把它的值标准化
INR0.9[3]1.2[3]INR是被检验者的凝血酶原时间的修正。
活化部分凝血活酶时间(Activated partial thromboplastin time (APTT))18[2], 30[6][3]28[2], 42[3], 45[6]s
凝血酶凝固时间 (TCT)1118s
纤维蛋白原1.7[2], 2.0[3]3.6[3], 4.2[2]g/L
抗凝血酶0.80[3]1.2[3]kIU/L
出血时间29min
粘度1.5[107]1.72[107]cP

急性期蛋白质

项目检验者下限值上限值单位参考
红细胞沉降率
(ESR)
男性0年龄÷2[108]mm/hr红细胞沉降率随着年龄的增长,女性往往偏高。[109]
女性(年龄+10)÷2 [108]
C-反应蛋白 (CRP)n/a5[110][3], 6[111]mg/L
200[112], 240[112]nmol/L
α1-抗胰蛋白酶 (AAT)20[113], 22[114]38[114], 53[113]μmol/L
89[115], 97[3]170[3], 230[115]mg/dL

抗体的种类

项目检验者下限值上限值单位参考
免疫球蛋白A(IgA)成人70[3], 110[116]360[3], 560[116]mg/dL
免疫球蛋白D(IgD)0.5[116]3.0[116]
免疫球蛋白E(IgE)0.01[116]0.04[116]
免疫球蛋白G(IgG)800[116]1800[116]
免疫球蛋白M(IgM)54[116]220[116]

自身抗体

项目阴性疑似阳性阳性单位
抗SS-A抗体 (Ro)< 15[117]15-25[117]> 25[117]Units
per
millilitre
(U/mL)
抗SS-B抗体 (La)< 3[117]3 – 4[117]> 4[117]
Anti ds-DNA< 40[117]40 – 60[117]> 60[117]
Anti ss-DNA< 8[117]8 - 10[117]> 10[117]
Anti-histone antibodies< 25[117]n/a[117]> 25[117]
Cytoplasmic/classical
抗中性粒细胞胞浆抗体 (c-ANCA)
< 20[117]21 - 30[117]> 30[117]
Perinuclear
anti-neutrophil cytoplasmic
antibodies (p-ANCA)
< 5[117]n/a> 5[117]
抗线粒体抗体 (AMA)< 10 [117]n/a[117]> 10[117]
类风湿因子 (RF)< 2020 - 30> 30[2]
抗链球菌溶血素 O titre
(ASOT)
(学龄前)
> 100
ASOT(就学期)> 250[2]
ASOT(成人)> 125[2]
项目阴性弱阳性中阳性高阳性单位
抗磷脂 IgG< 20[117]20 –30[117]31 – 50[117]> 51[117]GPLU/ml[117]
抗磷脂 IgM< 1.5[117]1.5 –2.5[117]2 – 9.9[117]> 10[117]MPL /ml [117]
抗磷脂 IgA< 10[117]10 -20[117]21 – 30[117]> 31[117]arb U/ml[117]
抗瓜氨酸蛋白抗体
(Anti-citrullinated protein antibodies)
< 20[117]20 – 39[117]40 - 59[117]> 60[117]EU[117]

其他酶及蛋白质

项目下限值上限值单位备注
乳酸脱氢酶 (LDH)50[20]150[20]U/L
0.4[42]1.7[42]μmol/L
LDH (酶的活性)1.8[3]3.4[3]µkat/L< 70歳[3]
淀粉25[1], 30[2], 53[20]110[2], 120[118], 123[20], 125[1], 190[42]U/L
0.15[3]1.1[3]µkat/L
200[112]240[112]nmol/L
D-二聚体n/a500[119]ng/mL妊妇で高い。[120]
0.5[3]mg/L
脂肪酶7[2], 10[20], 23[42]60[2], 150[20], 208[42]U/L
血管紧张素转换酶 (ACE)23[42]57[42]U/L
酸性磷酸酶3.0[42]ng/mL
嗜酸性粒细胞阳离子蛋白 (ECP)2.3[3]16[3]µg/L

其他电解质及代谢物

项目检验者类型下限值上限值单位参考
渗透压275[1], 280[20], 281[3]295[1], 296[20], 297[3]mOsm/kg不包含溶质的血浆重量
渗透压Slightly less than osmolalitymOsm/l包含溶质的血浆容量
尿素1.2[1], 3.0[121]3.0[1], 7.0[121]mmol/L尿素氮(BUN - Blood urea nitrogen)
7[1]18[1], 21[2]mg/dL
*尿酸[2]0.18[1]0.48[1]mmol/L
女性2.0[20]7.0[20]mg/dL
男性2.1 [20]8.5[20]mg/dL
肌酐男性60[3], 68[122]90[3], 118[122]μmol/L参见肌酐清除率
0.7[123], 0.8[123]1.0[123], 1.3[123]mg/dL
女性50[3], 68[122]90[3], 98[122]μmol/L
0.6[123], 0.8[123]1.0[123], 1.1[123]mg/dL
尿素氮/肌酐比5[20]35[20]-
血浆血糖值 (空腹时)3.8[1], 4.0[3]6.0[3], 6.1[124]mmol/L糖化血红蛋白
65[2], 70[1], 72[125]100[124], 110[20]mg/dL
总血糖値 (空腹时)3.3[3]5.6[3]mmol/L
60[125]100[125]mg/dL
乳酸 (静脉)4.5[20]19.8[20]mg/dL
0.5[126]2.2[126]mmol/L
乳酸 (动脉)4.5[20]14.4[20]mg/dL
0.5[126]1.6[126]mmol/L
丙酮酸300[20]900[20]μg/dL
34 [127]102[127]μmol/L

脂质

项目检验者类型下限值上限值单位最适范围
中性脂肪10 – 39 岁54[20]110[20]mg/dL< 100 mg/dL[31]
or 1.1[31] mmol/L
0.61[128]1.2 [128]mmol/L
40 – 59 岁70[20]150[20]mg/dL
0.77[128]1.7[128]mmol/L
> 60 岁80[20]150[20]mg/dL
0.9[128]1.7[128]mmol/L
胆固醇3.0[129], 3.6[1][129]5.0[3][130], 6.5[1]mmol/L< 3.9 [31]
120[2], 140[1]200[2], 250[1]mg/dL< 150 [31]
HDL胆固醇女性1.0[131], 1.2[3], 1.3[129]2.2[131]mmol/L> 1.0[131] or 1.6[129]  mmol/L
> 40[132] or 60[133] mg/dL
40[132], 50[134]86[132]mg/dL
HDL胆固醇男性0.9[131][3]2.0[131]mmol/L
35[132]80[132]mg/dL
LDL胆固醇
(中性脂肪 >5.0 mmol/L
的情况下无效)
2.0[131], 2.4[130]3.0[130][3], 3.4[131]mmol/L< 2.5 [131]
80[132], 94[132]120[132], 130[132]mg/dL< 100[132]
LDL/HDL比n/a5[3](unitless)

参考资料

  1. Last page of Deepak A. Rao; Le, Tao; Bhushan, Vikas. . McGraw-Hill Medical. 2007. ISBN 0-07-149868-0.
  2. Normal Reference Range Table 存檔,存档日期1998-04-24. from The University of Texas Southwestern Medical Center at Dallas. Used in Interactive Case Study Companion to Pathologic basis of disease.
  3. Reference range list from Uppsala University Hospital ("Laborationslista"). Artnr 40284 Sj74a. Issued on April 22, 2008
  4. Derived from molar values using molar mass of 22.99 g·mol−1
  5. Derived from molar values using molar mass of 39.10 g·mol−1
  6. MERCK MANUALS > Common Medical Tests > Blood Tests Last full review/revision February 2003
  7. Derived from molar values using molar mass of 35.45 g·mol−1
  8. Larsson, L.; Ohman, S. . Clinical Chemistry. 1978-11, 24 (11): 1962–1965. ISSN 0009-9147. PMID 709830.
  9. Derived from molar values using molar mass of 40.08  g·mol−1
  10. Slon S. . University of Illinois Medical Center. 2006-09-22 [2006-07-06]. (原始内容存档于2006-10-28).
  11. Diagnostic Chemicals Limited > Serum Iron-SL Assay 存檔,存档日期2009-01-06. July 15, 2005
  12. Derived from mass values using molar mass of 55.85 g·mol−1
  13. Table 1. 页面存档备份,存于 Page 133. Clinical Chemistry 45, No. 1, 1999 (stating 1.9–3.3 g/L)
  14. Derived by dividing mass values with molar mass
  15. Ferritin by: Mark Levin, MD, Hematologist and Oncologist, Newark, NJ. Review provided by VeriMed Healthcare Network
  16. Derived from mass values using molar mass of 450,000 g·mol−1
  17. Mitchell, M. L.; Filippone, M. D.; Wozniak, T. F. . Archives of Pathology & Laboratory Medicine. 2001-08, 125 (8): 1084–1087. ISSN 0003-9985. PMID 11473464. doi:10.1043/0003-9985(2001)1252.0.CO;2.
  18. Diaz, J.; Tornel, P. L.; Martinez, P. . Clinical Chemistry. 1995-07, 41 (7): 1048. ISSN 0009-9147. PMID 7600690.
  19. Derived from molar values using molar mass of 17.03 g/mol
  20. . www.bloodbook.com. [2020-12-25].
  21. Derived from mass values using molar mass of 63.55 g·mol−1
  22. Derived from mass using molar mass of 151kDa
  23. Derived from mass values using molar mass of 40.08  g·mol−1
  24. Walter F., PhD. Boron. . Elsevier/Saunders. 2005. ISBN 1-4160-2328-3. Page 849
  25. Reference range for copperGPnotebook
  26. (PDF). [2010-01-17]. (原始内容 (PDF)存档于2010-03-07).
  27. Derived from molar values using molar mass of 65.38 g/mol
  28. Derived from mass values using molar mass of 65.38 g/mol
  29. Derived from molar values using molar mass of 24.31 g/mol
  30. Derived from mass values using molar mass of 24.31 g/mol
  31. Adëeva Nutritionals Canada > Optimal blood test values 存檔,存档日期2009-05-29. Retrieved on July 9, 2009
  32. Middleton, P; Kelly, A‐M; Brown, J; Robertson, M. . Emergency Medicine Journal : EMJ. 2006-8, 23 (8): 622–624. ISSN 1472-0205. PMC 2564165. PMID 16858095. doi:10.1136/emj.2006.035915.
  33. The Medical Education Division of the Brookside Associates--> ABG (Arterial Blood Gas) Retrieved on Dec 6, 2009
  34. Derived from molar values using molar mass of 1.01 g·mol−1
  35. Derived from mmHg values using 0.133322 kPa/mmHg
  36. Derived from molar values using molar mass of 44.010 g/mol
  37. Derived from molar values using molar mass of 61 g/mol
  38. Reference range (albumin)GPnotebook
  39. Derived from mass using molecular weight of 65kD
  40. Derived from mass values using molar mass of 585g/mol
  41. Derived from molar values using molar mass of 585g/mol
  42. Fachwörterbuch Kompakt Medizin E-D/D-E. Author: Fritz-Jürgen Nöhring. Edition 2. Publisher:Elsevier, Urban&FischerVerlag, 2004. ISBN 3437151207, 9783437151200. Length: 1288 pages
  43. GPnotebook > reference range (AST) Retrieved on Dec 7, 2009
  44. Helander, A.; Vabö, E.; Levin, K.; Borg, S. . Clinical Chemistry. 1998-10, 44 (10): 2120–2125. ISSN 0009-9147. PMID 9761244.
  45. Creatine kinaseGPnotebook
  46. Saint Francis Hospital Laboratory > BNP reference range change 页面存档备份,存于 Jay Hupp & Dr. Michel S. Medawar. Effective November, 2002
  47. The University of Iowa (UIHC) > Department of Pathology > LABORATORY SERVICES HANDBOOK > N-terminal-pro-BNP 存檔,存档日期2008-10-11. Showing 95th percentiles. Epic Lab Code: LAB649. Updated: 10/27/2009
  48. Muscle Information and Courses from MediaLab, Inc. > Cardiac Biomarkers Retrieved on April 22, 2010
  49. South London Healthcare NHS Trust
  50. Moderately Elevated Serum Troponin Concentrations Are Associated With Increased Morbidity and Mortality Rates in Surgical Intensive Care Unit Patients Rene P. Relos, MD; Ian K. Hasinoff, MD; Greg J. Beilman, MD. Posted: 12/05/2003; Crit Care Med. 2003;31(11)
  51. Kay, Stephen E.; Doery, James; Sholl, David. . The Australian and New Zealand Journal of Psychiatry. 2002-02, 36 (1): 143–144. ISSN 0004-8674. PMID 11929456. doi:10.1046/j.1440-1614.2002.0988f.x.
  52. GP Notebook > range (reference, ca-125) Retrieved on Jan 5, 2009
  53. ClinLab Navigator > Test Interpretations > CA-125 存檔,存档日期2010-05-20. Retrieved on Jan 5, 2009
  54. Bjerner, Johan; Høgetveit, Anita; Wold Akselberg, Katrine; Vangsnes, Kirsti; Paus, Elisabeth; Bjøro, Trine; Børmer, Ole Petter; Nustad, Kjell. . Scandinavian Journal of Clinical and Laboratory Investigation. 2008, 68 (8): 703–713. ISSN 1502-7686. PMID 18609108. doi:10.1080/00365510802126836.
  55. Carcinoembryonic Antigen(CEA) at MedicineNet
  56. The TSH Reference Range Wars: What's "Normal?", Who is Wrong, Who is Right... By Mary Shomon, About.com. Updated: June 19, 2006. About.com Health's Disease and Condition
  57. 2006 Press releases: Thyroid Imbalance? Target Your Numbers 存檔,存档日期2008-03-03. Contacts: Bryan Campbell American] Association of Clinical Endocrinologists
  58. The TSH Reference Range Wars: What's "Normal?", Who is Wrong, Who is Right... By Mary Shomon, About.com. Updated: June 19, 2006
  59. Demers, Laurence M.; Carole A. Spencer. . National Academy of Clinical Biochemistry (USA). 2002 [2007-04-13]. - see Section 2. Pre-analytic factors
  60. Free T4; Thyroxine, Free; T4, Free 存檔,存档日期2010-12-22. UNC Health Care System
  61. Derived from mass values using molar mass of 776.87 g/mol
  62. Table 4: Typical reference ranges for serum assays 存檔,存档日期2011-07-01. - Thyroid Disease Manager
  63. Euthyroid Patient with Elevated Serum Free Thyroxine 页面存档备份,存于 George van der Watt1,a, David Haarburger1 and Peter Berman
  64. Derived from mass values using molar mass of 650.98 g/mol
  65. Serum concentration of free T3, free T4 and TSH in healthy children 页面存档备份,存于 Cioffi Michele; Gazzerro Patrizia; Vietri Maria Teresa; Magnetta Rosa; Durante Adriana; D'Auria Annamaria; Puca Giovanni Alfredo; Molinari Anna Maria ;
  66. . [2012-12-19]. (原始内容存档于2012-02-17).
  67. Derived from mass values using molar mass of 288.42g/mol
  68. Derived from molar values using molar mass of 288.42g/mol
  69. MedlinePlus > Testosterone Update Date: 3/18/2008. Updated by: Elizabeth H. Holt, MD, PhD, Yale University. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director
  70. reference range (FSH) GPnotebook. Retrieved on September 27, 2009
  71. Values taken from day 1 after LH surge in: Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Reto Stricker, Raphael Eberhart, Marie-Christine Chevailler, Frank A. Quinn, Paul Bischof and Rene´ Stricker. Clin Chem Lab Med 2006;44(7):883–887 PMID 16776638
  72. New York Hospital Queens > Services and Facilities > Patient Testing > Pathology > New York Hospital Queens Diagnostic Laboratories > Test Directory > Reference Ranges Retrieved on Nov 8, 2009
  73. GPNotebook - reference range (oestradiol) Retrieved on September 27, 2009
  74. Derived from molar values using molar mass of 272.38g/mol
  75. Wu, C. H.; Motohashi, T.; Abdel-Rahman, H. A.; Flickinger, G. L.; Mikhail, G. . The Journal of Clinical Endocrinology and Metabolism. 1976-08, 43 (2): 436–445. ISSN 0021-972X. PMID 950372. doi:10.1210/jcem-43-2-436.
  76. Derived from molar values using molar mass of 314.46 g/mol
  77. Derived from mass values using molar mass of 4540g/mol according to PROOPIOMELANOCORTIN; NCBI --> POMC Retrieved on September 28, 2009
  78. . WebMD. 09-03-2006 [2008-11-09].
  79. Derived from molar values using molar mass of 4540g/mol according to PROOPIOMELANOCORTIN; NCBI --> POMC Retrieved on September 28, 2009
  80. Biochemistry Reference Ranges at Good Hope Hospital Retrieved on Nov 8, 2009
  81. Derived from molar values using molar mass of 362 g/mol
  82. Derived from molar values using molar mass of 9.4 kDa
  83. Table 2 in: Aloia JF, Feuerman M, Yeh JK. . Endocr Pract. 2006, 12 (2): 137–44. PMC 1482827. PMID 16690460.
  84. Derived from mass values using molar mass of 9.4 kDa
  85. Derived from molar values using molar mass 400.6 g/mol
  86. Bender, David A. . . Cambridge: Cambridge University Press. 2003. ISBN 0-521-80388-8. Retrieved December 10, 2008 through Google Book Search.
  87. Bischoff-Ferrari, H.A., Dietrich, T., Orav, J.E., Hu, F.B., Zhang, Y., Karlson, E., Dawson-Hughes, B. 2004. Higher 25-hydroxyvitamin D levels are associated with better lower extremity function in both active and inactive adults 60+ years of age. American Journal of Clinical Nutrition. 80:752-758.
  88. Reusch, J.; Ackermann, H.; Badenhoop, K. . Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 2009-05, 41 (5): 402–407. ISSN 1439-4286. PMID 19241329. doi:10.1055/s-0028-1128131.
  89. Vasquez, Alex; Cannell, John. . BMJ. 2005-07-07, 331 (7508): 108–109. ISSN 0959-8138. PMID 16002891. doi:10.1136/bmj.331.7508.108-b (英语).
  90. . [2012-12-19]. (原始内容存档于2008-12-05).
  91. Derived from molar values using molar massof 135 g/mol
  92. Central Manchester University Hospitals --> Reference ranges 页面存档备份,存于 Retrieved on July 9, 2009
  93. University of Kentucky Chandler Medical Center > Clinical Lab Reference Range Guide 页面存档备份,存于 Retrieved on April 28, 2009
  94. Derived from mass values using molar mass of 441 mol−1
  95. GPnotebook > B12 Retrieved on April 28, 2009
  96. Derived form molar values using molar mass of 1355g/mol
  97. Derived from mass values using molar mass of 1355g/mol
  98. Derived from mass values using molar mass of 176 grams per mol
  99. For 醉酒駕駛 by country, see Drunk driving law by country
  100. Derived from mass values using molar mass of 46g/mol
  101. Derived from mass values using 64,500 g/mol, according to Van Beekvelt MC, Colier WN, Wevers RA, Van Engelen BG. . J Appl Physiol. 2001, 90 (2): 511–519. PMID 11160049.
  102. Derived from mass concentration, using molar mass of 64,458 g/mol (Van Beekvelt MC, Colier WN, Wevers RA, Van Engelen BG. . J Appl Physiol. 2001, 90 (2): 511–519. PMID 11160049.). 1 g/dL = 0.1551 mmol/L
  103. lymphomation.org > Tests & Imaging > Labs > Complete Blood Count Retrieved on May 14, 2009
  104. Clinical Laboratory Medicine. By Kenneth D. McClatchey. Page 807.
  105. Determination of monocyte count by hematological analyzers, manual method and flow cytometry in polish population Central European Journal of Immunology 1-2/2006. (Centr Eur J Immunol 2006; 31 (1-2): 1-5) authors: Elżbieta Górska, Urszula Demkow, Roman Pińkowski, Barbara Jakubczak, Dorota Matuszewicz, Jolanta Gawęda, Wioletta Rzeszotarska, Maria Wąsik,
  106. MedlinePlus百科全书 003652
  107. Retrieved on November 20, 2009
  108. Miller, A.; Green, M.; Robinson, D. . British Medical Journal (Clinical Research Ed.). 1983-01-22, 286 (6361): 266. ISSN 0267-0623. PMC 1546487. PMID 6402065. doi:10.1136/bmj.286.6361.266.
  109. Böttiger, L. E.; Svedberg, C. A. . British Medical Journal. 1967-04-08, 2 (5544): 85–87. ISSN 0007-1447. PMC 1841240. PMID 6020854. doi:10.1136/bmj.2.5544.85.
  110. C-reactive proteinGPnotebook
  111. 2730 Serum C-Reactive Protein values in Diabetics with Periodontal Disease 存檔,存档日期2008-12-20. A.R. Choudhury, and S. Rahman, Birdem, Diabetic Association of Bangladesh, Dhaka, Bangladesh. (the diabetics were not used to determine the reference ranges)
  112. Derived from mass using molar mass of 25,106 g/mol
  113. Sipahi, Tansu; Kara, Cengiz; Tavil, Betül; Inci, Ayşe; Oksal, Ayşegül. . Journal of Pediatric Hematology/Oncology. 2003-03, 25 (3): 274–275. ISSN 1077-4114. PMID 12621252. doi:10.1097/00043426-200303000-00019.
  114. Derived from mass values using molar mass of 44324.5 g/mol
  115. Derived from molar values using molar mass of 44324.5 g/mol
  116. The Society for American Clinical Laboratory Science > Chemistry Tests > Immunoglobulins 存檔,存档日期2009-10-15. Retrieved on Nov 26, 2009
  117. chronolab.com > Autoantibodies associated with rheumatic diseases > Reference ranges Retrieved on April 29, 2010
  118. Reference range (amylase)GPnotebook
  119. Plasma Measurement of D-Dimer Levels for the Early Diagnosis of Ischemic Stroke Subtypes Walter Ageno, MD; Sergio Finazzi, MD; Luigi Steidl, MD; Maria Grazia Biotti, MD; Valentina Mera, MD; GianVico Melzi d'Eril, MD; Achille Venco, MD. Arch Intern Med. 2002;162:2589-2593.
  120. Kline, Jeffrey A.; Williams, Ginger W.; Hernandez-Nino, Jackeline. . Clinical Chemistry. 2005-05, 51 (5): 825–829. ISSN 0009-9147. PMID 15764641. doi:10.1373/clinchem.2004.044883.
  121. Gardner, M D; Scott, R. . Journal of Clinical Pathology. 1980-04, 33 (4): 380–385. ISSN 0021-9746. PMC 1146084. PMID 7400337. doi:10.1136/jcp.33.4.380.
  122. Finney, H.; Newman, D. J.; Price, C. P. . Annals of Clinical Biochemistry. 2000-01,. 37 ( Pt 1): 49–59. ISSN 0004-5632. PMID 10672373. doi:10.1258/0004563001901524.
  123. Derived from molar values by multiplying with the molar mass of 113.118 g/mol, and divided by 10.000 to adapt from μg/L to mg/dL
  124. MedlinePlus百科全书 Glucose tolerance test
  125. Derived from molar values using molar mass of 180g/mol
  126. Derived from mass values using molar mass of 90.08 g/mol
  127. Derived from mass values using molar mass of 88.06 g/mol
  128. Derived from values in mg/dl to mmol/l, by dividing by 89, according to faqs.org: What are mg/dl and mmol/l? How to convert? Glucose? Cholesterol? Last Update July 21, 2009. Retrieved on July 21, 2009
  129. Derived from values in mg/dl to mmol/l, using molar mass of 386.65 g/mol
  130. Reference range (cholesterol)GPnotebook
  131. Royal College of Pathologists of Australasia; Cholesterol (HDL and LDL) - plasma or serum Last Updated: Monday, 6 August 2007
  132. Derived from values in mmol/l, using molar mass of 386.65 g/mol
  133. What Your Cholesterol Levels Mean. American Heart Association. Retrieved on September 12, 2009
  134. . [2012-12-19]. (原始内容存档于2001-09-03).

关联项目

外部链接


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.